Last reviewed · How we verify
Silver nanoparticles
At a glance
| Generic name | Silver nanoparticles |
|---|---|
| Also known as | Topical jel |
| Sponsor | Ahmed A. H. Abdellatif |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Silver Diamine Fluoride Versus Nano-Silver Fluoride in Arresting Active Dentin Caries in Primary Teeth in Young Children (NA)
- Efficacy of Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel (PHASE3)
- Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair (NA)
- Children Acceptance of AgNP Mouthwash Against Chlorhexidine Mouthwash (NA)
- Comparative Study of Negative-Pressure Wound Therapy Integrated With Silver Nanoparticle Spray Versus Negative-Pressure Wound Therapy in Post-Revascularization Diabetic Foot Wound Management
- The Comparative Effects of Using 0.12% Chlorhexidine and Silver Nanoparticles Mouthwashes in Medical Students (PHASE3)
- Analyzing the Effect of Disinfection Additives on the Linear Dimensional Stability of Dental Alginate Impressions: A Quasi-Experimental Comparative Study (NA)
- The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Silver nanoparticles CI brief — competitive landscape report
- Silver nanoparticles updates RSS · CI watch RSS
- Ahmed A. H. Abdellatif portfolio CI